Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix
Open Access
- 4 August 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 85 (3), 413-423
- https://doi.org/10.1093/cvr/cvp268
Abstract
Matrix metalloproteinase (MMP)-2 belongs to a family of zinc-dependent proteases which are best known for their ability to proteolyse extracellular matrix proteins throughout the body, including the cardiovascular system. Increased MMP-2 activity has been demonstrated in myocardial ischaemia and reperfusion injury and the progression to congestive heart failure, with most evidence to date for its role in cardiac remodelling. Recent evidence, however, shows that MMP-2 also co-localizes with and proteolyses specific protein targets within the cardiomyocyte to cause acute, reversible contractile dysfunction, challenging the conventional wisdom on the ‘extracellular matrix only’ actions of this enzyme. In this review, we discuss the recent upsurge in MMP-2 research with regards to its activation by non-proteolytic pathways in the setting of enhanced oxidative stress in the heart. We will focus on the consequences of intracellular actions of MMP-2 within the cardiomyocyte and its regulation at several levels including its expression, post-translational modifications, and regulation by endogenous tissue inhibitors of metalloproteinases, caveolin, and small molecule MMP inhibitors. MMP-2 is emerging as an important signalling protease implicated in the proteolytic regulation of various intracellular proteins in myocardial oxidative stress injury.This publication has 99 references indexed in Scilit:
- Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and ReperfusionCirculation, 2008
- Cardiac Uptake of Minocycline and Mechanisms for In Vivo CardioprotectionJournal of the American College of Cardiology, 2008
- Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyteBritish Journal of Pharmacology, 2008
- Metalloproteinases and Vulnerable Atherosclerotic PlaquesTrends in Cardiovascular Medicine, 2007
- Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureBritish Journal of Pharmacology, 2007
- Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunctionBiochemical and Biophysical Research Communications, 2007
- Glycogen synthase kinase-3β plays a pro-apoptotic role in β-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of β1 integrinsJournal of Molecular and Cellular Cardiology, 2007
- Elevated glucose inhibits VEGF-A–mediated endocardial cushion formationThe Journal of cell biology, 2003
- MMP-2 Colocalizes with Caveolae on the Surface of Endothelial CellsExperimental Cell Research, 2001